Summaries of health policy coverage from major news organizations
Roche to Submit Price Reduction Proposal for Viracept to Brazilian Health Ministry
Roche Holding AG's President of Brazilian operations Ernest Egli yesterday submitted to Brazilian Health Minister Jose Serra a new proposal to cut the price of Roche's AIDS drug Viracept, according to Brazil's O Globo newspaper (AFX News, 8/29). Brazilian officials announced last week that they would break Roche's patent on Viracept, known generically as nelfinavir, if Roche did not lower the drug's price. Roche offered to cut Viracept's price by 13% earlier this year, but the Brazilian Health Ministry rejected the offer. Brazil currently produces eight antiretrovirals locally and distributes them free of charge as part of its AIDS program (Kaiser Daily HIV/AIDS Report, 8/21).
This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.